Abstract:
The treatment of pediatric obesity is an urgent clinical priority because it prevents long-term health complications such as atherosclerosis, type 2 diabetes, high blood pressure, and various cancers that contribute to premature mortality and increased hospitalization. While lifestyle-based management is the standard starting point, it often results in significant weight regain—between 40% and 65% within two years—due to biological mechanisms that increase hunger and metabolic efficiency as the body resists weight loss. The American Academy of Pediatrics suggests that severe obesity is unlikely to be managed by lifestyle programs alone, making more intensive interventions necessary. Pharmacological treatments like Phentermine/Topiramate and Semaglutide are the most effective options currently available for reducing BMI in adolescents, serving as a critical bridge in treatment. However, these medications can cause gastrointestinal side effects, and weight loss is typically only maintained during active use; additionally, insurance coverage remains a significant barrier for many pediatric patients. For more durable and substantial weight loss, bariatric and metabolic surgery is recognized as a safe and effective strategy for severe pediatric obesity, offering rapid reversal of comorbidities and long-term total body weight loss of 26% to 29%. The primary procedures include the Sleeve Gastrectomy, which removes a large portion of the stomach to restrict volume and reduce the hunger hormone ghrelin, and the Roux-En-Y Gastric Bypass, which provides both restrictive and malabsorptive benefits. Candidates for these surgeries are typically developmentally mature with a BMI of 35 or higher accompanied by comorbidities, or a BMI of 40 or higher. Achieving successful outcomes requires a multidisciplinary approach involving surgeons, pediatricians, psychologists, and nutritionists to ensure comprehensive support. The pediatrician plays a central role in early intervention and the lifelong monitoring of nutritional status, specifically for deficiencies in iron and Vitamin B12. The overarching goal of these medical and surgical interventions is to normalize life expectancy and prevent cumulative organ damage rather than focusing solely on aesthetic weight metrics.
